Thank you to the generous donations of our corporate sponsors. We thank you from
the bottom of our hearts.
Please
join us in finding gentler
cures for children by becoming
a corporate
partner.
About Us:
History
The I Care I Cure Foundation was founded by Beth and Brad Besner (along with their friends and family) in honor of their son, Ian, who was diagnosed with T-Cell Acute Lymphoblastic Leukemia (ALL) in January, 2006, one week before his 11th birthday. Ian was an extraordinary boy who shared his joy and love of life with everyone who met him.
Ian was an exceptionally gifted student, with an unquenchable thirst for knowledge and an acute curiosity about the world around him. As passionate as Ian was about learning and reading, he was equally passionate about baseball and was a talented little league pitcher and an avid major league and college (UM) baseball fan. He also loved guitar, karate, rollerblading, roller hockey, skateboarding, travel, skiing – you name it, he wanted to try it and be great at it. And he usually was. And, like many kids his age, Ian also loved to “yuck” it up with his brothers and friends and get them to laugh whenever possible. He was witty and fun. In essence, Ian had a love of life and life’s experiences that was irresistible and infectious.
When Ian was diagnosed with leukemia, his whole world fell apart. He was bitterly angry. While the “cure” rate for ALL has come a long way with “cure” rates of 75-80% “, the reality of pediatric cancer treatment is excruciatingly difficult. Ian’s treatment was to last about 2 ½, years and entail massive doses of toxic chemotherapies administered orally, intravenously, through frequent shots to his legs and spine, and radiation to his brain. To a bright, joyful, enthusiastic child, this so-called “cure” was a death sentence – the end of life as he knew it.
Ian’s
treatment
required
him
to
stay
out
of
school
and
away
from
friends
because
of
low
immunities.
Current
chemotherapy
kills
all
fast-replicating
cells
–
the
good
and
the
bad
--
instead
of
just
the
cancer-causing
cells.
This
shotgun
approach
to
treatment,
leaves
no
white
blood
cells
to
ward
off
infection
and
causes
hair
loss.
Ian
was
ashamed
of
his
appearance
and
his
physical
weakness
and
was
embarrassed
to
see
friends.
He
was
isolated
and
lonely
much
of
the
time
and
frustrated
with
his
physical
limits.
And
when
he
should
have
been
gaining
independence,
Ian’s
choices
were
now
left
to
his
doctors
and
parents
who
needed
to
save
his
life.
He
suffered
anxiety
each
and
every
time
he
had
to
go
to
the
hospital
as
he
knew
what
he
was
facing
–
vomiting,
painful
mouth
sores,
pain,
nausea,
blood
transfusions,
and
more
vomiting. Ian
often
asked
why
the
“cure”
had
to
hurt
so
much.
Unfortunately, Ian died on May 31, 2006, just four months after his diagnosis and after four months of bravely enduring an excruciatingly difficult chemotherapy regimen. While Ian was cancer-free after just 15 days of treatment, following several more rounds of toxic chemotherapy, he had no immune system with which to fight meningitis that infected him. He was gone within weeks of entering the hospital with a fever. Plain and simply, the drugs that were supposed to save Ian’s life, ended up killing him
After
Ian
died,
his
parents
thought
often
about
Ian’s
question
.
.
.
why
DOES
pediatric
cancer
treatment
have
to
be
so
hard?
Can
it
be
improved?
What
is
being
done
to
improve
treatments
and
to
limit
the
horrendous
side
effects
of
treatments?
Why
do
there
have
to
be
such
debilitating
long-term
emotional
and
health
problems
after
treatment?
Having
had
to
witness
their
child
suffer,
the
Besners
wanted
to
spare
other
children
and
their
parents
that
agony.
Having
found
themselves
dumbfounded
when
Ian
was
ill,
the
Besners
realized
that
much
of
the
public
is
completely
unaware
of
the
pain
and
suffering
kids
endure
under
current
chemotherapy
regimens.
I Care I Cure is dedicated to Ian Besner whose name inspired the "I" and whose spirit and courage will empower and inspire kids and adults alike to CARE about our communities and to CURE childhood cancer.